Comparative effect of dipeptidyl-peptidase 4 inhibitors on laboratory parameters in patients with diabetes mellitus

Abstract Background The purpose of this study was to evaluate and compare the effects on laboratory parameters among monotherapy with five DPP-4 inhibitors in patients with type 2 diabetes mellitus (DM). Methods We identified cohorts of new sitagliptin users (n = 879), vildagliptin users (n = 253),...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Yayoi Nishida, Yasuo Takahashi, Kotoe Tezuka, Hayato Akimoto, Tomohiro Nakayama, Satoshi Asai
Materialtyp: Artigo
Språk:Inglês
Publicerad: BMC 2020-04-01
Serie:BMC Pharmacology and Toxicology
Ämnen:
Diabetes mellitus
Dipeptidyl-peptidase 4 inhibitor
Sitagliptin
Vildagliptin
Teneligliptin
Alogliptin
Länkar:http://link.springer.com/article/10.1186/s40360-020-00407-4
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!
Laddar...

Liknande verk